Alchemy - Issue 28 | Page 25

Finished business After four years at the helm of its business development endeavours, Dr Rocco Iannello was recently farewelled by the faculty. As director of business development at MIPS, Dr Iannello worked primarily across the pharmacy and medicine faculties at Monash. He drove and facilitated inter-disciplinary research collaboration across both faculties and led the business development, industry engagement and commercialisation strategies across these faculties and, where required, the broader university. Professor Bill Charman said Dr Iannello had been instrumental in guiding the strategic direction of the faculty’s business development initiatives and achieving some outstanding results. “Rocco Iannello has been a fabulous contributor to the growth of MIPS and the Centre for Medicine Use and Safety, and to our overall research enterprise. He has led the structuring and negotiation of our major corporate and collaborative partnerships and has been the lynchpin in our interaction with the technology transfer and commercialisation activities of the University. He has had a passion for supporting our researchers, and contributed significantly to the MIPS Executive Committee,” he said. Dr Iannello will head up the international business development activities of Gordagen Pharmaceuticals Pty Ltd, which focuses on developing biopharmaceutical therapeutic agents and evidence-based nutraceuticals. “Rocco leaves with our best wishes for his future career, and our gratitude for a job very well done. He is a friend of us all at the Parkville campus – and I am sure we will see him into the future as we follow his, and he follows our, future progress,” Professor Charman said. “Rocco Iannello has been a fabulous contributor to the growth of MIPS and the Centre for Medicine Use and Safety, and to our overall research enterprise.” Taking over the reins from Dr Iannello is Joy Hewitt (BPharm 1988). Joy is a graduate of the faculty and holds an MBA (entrepreneurship and innovation) from the Australian Graduate School of Entrepreneurship, a Master of Laws (commercial law) from Monash and has completed a Company Directors Course at the Australian Institute of Company Directors. Most recently, she was director of business development at Biota following prior experience at EQiTX Limited as chief commercialisation officer and at CSL Limited as business development manager (pharmaceuticals). 23